National Health Investors Inc
NYSE: NHI · REAL ESTATE · REIT - HEALTHCARE FACILITIES
Updated 2026-06-05
National Health Investors Inc (NHI) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for NHI.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
NHI historical valuation range
Where current P/E sits in NHI's own 5Y range.
NHI intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
NHI valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 23.26x
P/S Ratio — History
Current: 8.64x
Is NHI overvalued in 2026?
National Health Investors Inc (NHI) currently trades at $73.43 per share with a market capitalization of $3,494,765,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 48/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 23.3x, below its 5-year median of 24.5x. The PEG ratio of 4.76 indicates the price has run ahead of the underlying growth rate.
Looking at its own history, NHI is currently trading cheaper than 67% of the last 5Y on P/E. This places it in the 33th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates NHI's intrinsic value at $129.13 per share, against the current market price of $73.43. This implies a margin of safety of +31.66%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: NHI appears richly valued on our framework, with a Smart Value Score of 48/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is NHI overvalued?
NHI scores 48/100 on our Smart Value Score (Grade C), a weak overall profile. The DCF also shows a positive margin of safety, so price and fundamentals line up reasonably well.
What is NHI's fair value?
Our DCF model estimates NHI's intrinsic value at $129.13 per share, versus the current price of $73.43, a margin of safety of +31.66%. Fair value is the present value of the cash flows we project the business to produce, so a price below it means the market is pricing the stock below that conservative estimate.
What P/E ratio does NHI trade at?
NHI trades at a P/E of 23.3x on trailing twelve-month earnings, against a 5-year median of 24.5x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.
Is NHI a buy based on valuation?
Our Smart Value rating for NHI is Sell, from a Smart Value Score of 48/100 that blends growth, quality, and valuation. The profile skews cautious, and a better price or clearer operating improvement would strengthen the case. This is research to inform your decision, not personalized financial advice.
How does NHI's valuation compare to its history?
On P/E, NHI sits in the 33rd percentile of its own 5Y range, below its long-run median relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.
What is NHI's Smart Value Score?
NHI's Smart Value Score is 48/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.